​

LivaNova (LIVN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LIVN Stock Forecast

LivaNova (LIVN) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $72.20, with a high of $81.00 and a low of $66.00. This represents a 12.46% increase from the last price of $64.20.

$45 $53 $61 $69 $77 $85 High: $81 Avg: $72.2 Low: $66 Last Closed Price: $64.2

LIVN Stock Rating

LivaNova stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (71.43%), 3 Hold (21.43%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 3 10 Strong Sell Sell Hold Buy Strong Buy

LIVN Price Target Upside V Benchmarks

TypeNameUpside
StockLivaNova12.46%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.94%

Price Target Trends

1M3M12M
# Anlaysts257
Avg Price Target$66.50$72.20$67.43
Last Closing Price$64.20$64.20$64.20
Upside/Downside3.58%12.46%5.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26362--11
Dec, 25352--10
Nov, 25253--10
Oct, 25262--10
Sep, 25262--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 09, 2026Barclays$67.00$64.953.16%4.36%
Jan 09, 2026David RomanGoldman Sachs$66.00$64.951.62%2.80%
Dec 19, 2025Brett FishbinKeyBanc$81.00$62.0830.48%26.17%
Dec 17, 2025Anthony PetroneMizuho Securities$72.00$63.0814.14%12.15%
Dec 16, 2025Robert W. Baird$75.00$63.0518.95%16.82%
Oct 01, 2025Goldman Sachs$55.00$52.385.00%-14.33%
Mar 07, 2025Barclays$56.00$39.1742.97%-12.77%
Oct 31, 2024Anthony PetroneMizuho Securities$70.00$51.0537.12%9.03%
Oct 04, 2024David RomanGoldman Sachs$65.00$53.9020.59%1.25%
Sep 17, 2024David RescottRobert W. Baird$66.00$48.7935.27%2.80%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 09, 2026Goldman SachsNeutralNeutralhold
Dec 19, 2025KeyBancOverweightinitialise
Oct 01, 2025Goldman SachsBuyNeutraldowngrade
May 20, 2025Wolfe ResearchOutperformupgrade
Feb 21, 2024NeedhamBuyBuyhold
Feb 20, 2024Mizuho SecuritiesBuyupgrade
Oct 23, 2023NeedhamBuyBuyhold
Dec 21, 2022BarclaysEqual-Weightinitialise
Nov 23, 2022Goldman SachsBuyBuyhold
Aug 16, 2022Goldman SachsBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 $5 $6 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.68$-1.61$0.33$1.17----
Avg Forecast$2.08$2.32$2.71$3.37$3.66$4.00$4.53$4.96
High Forecast$2.11$2.37$2.77$3.40$3.75$5.10$4.61$5.05
Low Forecast$2.06$2.19$2.67$3.35$3.57$2.64$4.31$4.72
Surprise %-228.85%-169.40%-87.82%-65.28%----

Revenue Forecast

$950M $1B $1B $1B $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04B$1.02B$1.15B$1.25B----
Avg Forecast$1.03B$1.01B$1.13B$1.26B$1.33B$1.40B$1.46B$1.55B
High Forecast$1.04B$1.02B$1.14B$1.27B$1.34B$1.41B$1.48B$1.57B
Low Forecast$1.03B$966.50M$1.09B$1.25B$1.32B$1.39B$1.44B$1.49B
Surprise %0.29%1.24%1.94%-0.23%----

Net Income Forecast

$-150M $-60M $30M $120M $210M $300M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-135.70M$-86.20M$17.55M$63.20M----
Avg Forecast$-76.67M$-14.42M$17.55M$182.88M$198.62M$209.82M$241.84M$268.89M
High Forecast$-61.34M$-3.91M$30.34M$184.24M$203.53M$276.57M$249.87M$273.59M
Low Forecast$-92.01M$-24.94M$4.75M$181.53M$193.71M$143.06M$233.81M$256.00M
Surprise %76.99%497.64%--65.44%----

LIVN Forecast FAQ

Is LivaNova stock a buy?

LivaNova stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that LivaNova is a favorable investment for most analysts.

What is LivaNova's price target?

LivaNova's price target, set by 14 Wall Street analysts, averages $72.2 over the next 12 months. The price target range spans from $66 at the low end to $81 at the high end, suggesting a potential 12.46% change from the previous closing price of $64.2.

How does LivaNova stock forecast compare to its benchmarks?

LivaNova's stock forecast shows a 12.46% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (19.94%).

What is the breakdown of analyst ratings for LivaNova over the past three months?

  • January 2026: 27.27% Strong Buy, 54.55% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 30.00% Strong Buy, 50.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 20.00% Strong Buy, 50.00% Buy, 30.00% Hold, 0% Sell, 0% Strong Sell.

What is LivaNova’s EPS forecast?

LivaNova's average annual EPS forecast for its fiscal year ending in December 2025 is $3.66, marking a 212.82% increase from the reported $1.17 in 2024. Estimates for the following years are $4 in 2026, $4.53 in 2027, and $4.96 in 2028.

What is LivaNova’s revenue forecast?

LivaNova's average annual revenue forecast for its fiscal year ending in December 2025 is $1.33B, reflecting a 5.75% increase from the reported $1.25B in 2024. The forecast for 2026 is $1.4B, followed by $1.46B for 2027, and $1.55B for 2028.

What is LivaNova’s net income forecast?

LivaNova's net income forecast for the fiscal year ending in December 2025 stands at $198.62M, representing an 214.27% increase from the reported $63.2M in 2024. Projections indicate $209.82M in 2026, $241.84M in 2027, and $268.89M in 2028.